Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
Promarker
Biotech Stocks Healthcare Stocks Life Sciences Small Caps Stocks Undervalued Stocks
Proteomics has launched 2 Promarker tests in a matter on months and is about to launch a 3rd
Proteomics' suite of Promarker tests are all being launched in 2025. The range includes: PromarkerD for DKD which has been launched in Australia and the USA; PromarkerEso for Esophageal cancer which is now commercially available in Australia, and PromarkerEndo for Endometriosis which will be commercialised shortly. Launching 3 tests in a a year is…
September 26, 20250Comments
maas group
Growth Stocks Industrials Market news Mid Cap Stocks Real Estate Small Caps Stocks Undervalued Stocks
Maas Group (ASX:MGH): Why investors should keep a keen eye on it in FY26!
It is a tough time to be a construction company, but Maas Group (ASX:MGH) hasn't fared that bad all things considered. This company, which is roughly double its IPO price, recorded another good FY25 result, and investors took note of it. But the company is still very reasonably priced. What are the Best stocks to invest…
September 26, 20250Comments
Qantas A321XLRs
Airlines Blue Chip Stocks Industrials Large Caps
What will the Qantas A321XLRs mean for the group? Hint: Investors should be excited but also cautious!
The first of Qantas A321XLRs is now taking passenger flights - the first flight occurred today (September 25) and it will be the first of many! Plenty has been (and will be) written about what it means for passengers. But we thought we'd focus on what it will mean for investors in Qantas. What are the Best…
September 25, 20250Comments
Myer
Consumer Retail
Myer (ASX:MYR): Investors hated its FY25 results with a passion, but the company is optimistic better times are ahead
Myer (ASX:MYR) made headlines earlier this week after its FY25 results - shares fell >25%. Were results that bad? Maybe not that bad, but they manifested problems investors arguably thought either weren't as bad or closer to a resolution than they previously envisioned. What are the Best ASX Stocks to invest in right now? Check our…
September 25, 20250Comments
Atlas Arteria
Blue Chip Stocks Industrials
Atlas Arteria (ASX:ALX): Meet the ASX’s other toll road operator – a company with no exposure to Australia
Atlas Arteria (ASX:ALX) is one of two toll road operators on the ASX, with the other being Transurban (ASX:TCL). But while Transurban is mostly focused on Australia, particularly Sydney, Atlas Arteria does not anymore. We thought we'd take a look at how the two companies compare. Spoiler alert: They face many of the same issues,…
September 24, 20250Comments
St George Mining
Mining Stocks Rare Earths Stocks
St George Mining has surged from $50m to >$250m in just 5 months and its latest drilling results are spectacular!
St George Mining (ASX:SGQ) has had a spectacular few months capped off with its latest drilling results. Its Araxa Niobium-REE Project in Brazil lies next to a mine that is one of the world's very few producing niobium mines and is also the world's largest. It has an Independent JORC Mineral Resource Estimate (MRE) of…
September 23, 20250Comments
Biotech Stocks Healthcare Stocks Life Sciences Small Caps Stocks
Amplia Therapeutics (ASX:ATX): Battling pancreatic cancer with an FAK inhibitor
Amplia Therapeutics (ASX:ATX) is another ASX oncology biotech company, attempting to battle cancer. At first glance, it may not a unique company but when you dig deeper...it is. It is using an 'FAK inhibitor' to fight pancreatic cancer (and potentially other indications down the track). What are the Best ASX Stocks to invest in right now?…
September 23, 20250Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here